Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
基本信息
- 批准号:7561648
- 负责人:
- 金额:$ 36.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgonistAllergicAspirinAsthmaBiologicalBiological AssayBronchial SpasmChronicChronic SinusitisCloningDataDiseaseElectrophoretic Mobility Shift AssayEndotheliumEpitheliumFeedbackFibrosisGenesGenetic TranscriptionGlandGrantHyperplasiaIndividualInflammationInflammatoryInterleukin-13Interleukin-4InterleukinsInvestigationKnockout MiceLeukotrienesLung diseasesMediatingMolecularMucous body substanceNasal PolypsOccupationsPathway interactionsProceduresProcessProductionReactionRegulationReportingResearch PersonnelRoleSignaling ProteinSinusitisSiteSyndromeTherapeuticTranscriptional RegulationUp-RegulationWorkairway remodelingbasecysteinyl leukotriene receptor 2cysteinyl-leukotrienecytokinedesensitizationeffective therapyeosinophilhuman IRS2 proteinin vivoleukotriene-C4 synthasepromoterreceptorreceptor expressionrespiratory smooth muscletranscription factor
项目摘要
This grant will investigate the pro-inflammatory feedback reaction that develops between interleukin (IL)-4
(and other cytokines) and cysteinyl leukotrienes (CysLTs) that leads to the inflammation, hyperplasia, and
airway remodeling observed in chronic hyperplastic eosinophilic sinusitis (CHES) and asprin-exacerbated
respiratory disease (AERD). AERD is a syndrome characterized by severe persistent asthma, aggressive
airway remodeling, extensive hyperplastic eosinophilic sinusitis with nasal polyp (NP) formation, and
intolerance to aspirin. Eosinophils are essential to the fibrotic processes associated with asthma and CHES.
Aspirin intolerance reflects increased expression of leukotriene C4 synthase (LTC4S) and CysLT receptor
expression and, as a result, these subjects have constitutive overproduction and heightened responsiveness
to CysLTs. CysLTs function through their ability to interact with two homologous receptors: CysLTI and
CysLT2 both of which are highly upregulated in AERD. We hypothesize that CysLTs contribute to the
hyperplasia, fibrosis, and remodeling of AERD through their activation of eosinophils. Both the pathway
responsible for CysLT synthesis and the expression of CysLT receptors are tightly regulated by cytokines,
including prominently, IL-4. This pro-inflammatory feedback between CysLTs and IL-4 promotes eosinophil-
mediated inflammation, mucus gland secretion, and the proliferation of airway smooth muscle, epithelium,
and endothelium, leading to fibrosis. In specific aim #1 we will dissect individual roles for CysLTI and
CysLT2 receptors in these processes. Our hypothesis is that whereas the CysLTI receptor may be uniquely
involved in bronchospasm, the upregulation of CysLT2 receptor-dependent pathways has more important
remodeling functions in CHES/AERD. Specific aim #2 will investigate the regulation of CysLT receptors and
LTC4S expression by IL-4. Finally, aspirin desensitization is an effective treatment for AERD. Therefore
specific aim #3 will investigate the role of IL-4 antagonism by aspirin as the therapeutic basis for the efficacy
of this procedure
该基金将研究白细胞介素(IL)-4之间的促炎反馈反应
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY C BORISH其他文献
LARRY C BORISH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY C BORISH', 18)}}的其他基金
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的持久临床和炎症反应
- 批准号:
10540527 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9893778 - 财政年份:2016
- 资助金额:
$ 36.08万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9081696 - 财政年份:2016
- 资助金额:
$ 36.08万 - 项目类别:
Clinical immune response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床免疫反应
- 批准号:
9075457 - 财政年份:2015
- 资助金额:
$ 36.08万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
8077929 - 财政年份:2010
- 资助金额:
$ 36.08万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
7975934 - 财政年份:2010
- 资助金额:
$ 36.08万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7167443 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i
LTE4/LTE4 受体和 IFN-γ 与肥大细胞和嗜酸性粒细胞之间的相互作用
- 批准号:
8450125 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7103793 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7761238 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:














{{item.name}}会员




